Janux Therapeutics, Inc. · NASDAQ:JANX
FMR LLC reported a 5.80% stake in Janux Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 8, 2026
FMR LLC reported a 5.80% stake in Janux Therapeutics, Inc., 3,512,384 shares, as a passive investor on Dec 31, 2025. Filed Jan 8, 2026 (Schedule 13G/A).
- Stake
- 5.80%
- Shares
- 3,512,384
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 5.80% | 3,512,384 |
| Abigail P. Johnson | 5.80% | 3,512,384 |
Source
Related
- Janux Therapeutics, Inc.
- FMR LLC
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026